The peer-authored management source for clinical lab professionals since 1969.
Continuing Education
Diagnostics
Disease
Management
Molecular
Sections
Continuing Education
Diagnostics
Disease
Management
Molecular
Information Technology
Online Exclusives
Special
Magazine
Newsletter
Webinars
White Papers
eBooks
Clinical Laboratory Reference
Videos
Events
Contact
About Us
Magazine Subscription
Newsletter Subscription
Advertise
Contact Us
Affiliated Brands
HEALTHCARE PURCHASING NEWS
HEALTHCARE INNOVATION
Follow us on
https://www.facebook.com/MLOMedicalLaboratoryObserver
https://www.linkedin.com/company/medical-laboratory-observer
https://twitter.com/MedicalLabMLO
Diagnostics
ID 87380942 © Nataliia Mysik | Dreamstime.com
Diagnostics
A case for alanine transaminase (ALT) testing
Perhaps the most underappreciated organ in the human body is the liver. It is one of the largest organs in the body, and unlike other vital organs such as the skin and kidneys...
Oct. 27, 2025
By hardvicore on Adobe Stock
Diagnostics
Neurogen and Tasso partner to enhance Alzheimer’s testing with painless blood collection
Nov. 26, 2025
ID 137226375 © Christian Weiß | Dreamstime.com
Pathology
New CAP guidelines standardize amyloidosis diagnosis for better patient outcomes
Nov. 25, 2025
By Studio Romantic on Adobe Stock
MDX
Diasorin submits FDA premarket notification for LIAISON PLEX Gastrointestinal Flex Assay
Nov. 25, 2025
By Peakstock on Adobe Stock
Diagnostics
Roche research reveals cervical cancer screening gaps in millennials
Nov. 24, 2025
ID 169772619 © Fizkes | Dreamstime.com
Diagnostics
Thermo Fisher's Oncomine Dx test gains FDA approval as companion diagnostic for HER2-targeted NSCLC therapy
Nov. 21, 2025
By Alexander Raths on Adobe Stock
Diagnostics
PrognomiQ introduces ProVue Lung: Enhancing early detection of lung cancer
Nov. 20, 2025
ID 154936575 © Chernetskaya | Dreamstime.com
Assays
BD Onclarity HPV Assay achieves WHO prequalification to expand cervical cancer screening
Nov. 19, 2025
ID 18889635 © Vetpathologist | Dreamstime.com
Diagnostics
FDA Approves Promega OncoMate MSI Dx Analysis System for endometrial carcinoma treatment guidance
Nov. 18, 2025
Looking for Something?
Load More Content